Merck & Co. Inc. Logo

Merck & Co. Inc. (MRCK34)

(Delisted)

Bovespa

Currency in BRL
83.39
0.00 (0.00%)

Closed

Jul 24, 2026

Day's Range

82.91
83.72

52 wk Range

51.86
84.81

Profile - MRCK34 - Merck & Co. Inc.

Profile

Mic Code

BVMF

Sector

Healthcare

Industry

Drug Manufacturers - General

Employees

73K


Merck & Co. Inc. is a renowned pharmaceutical company that plays a crucial role in the healthcare industry by developing, manufacturing, and marketing innovative medicines and vaccines. Its primary function is to provide effective and safe treatment options for various medical conditions, thereby improving global health outcomes. The company's product portfolio spans across sectors such as oncology, cardiology, endocrinology, and vaccines, impacting multiple facets of human health and well-being. Known for its emphasis on research and development, Merck invests heavily in scientific innovation to address unmet medical needs. This dedication to advancing healthcare contributes significantly to its prominence in the pharmaceutical market, making it a key player in both the development of new therapies and the global distribution of essential medicines. Established in 1891 and headquartered in Kenilworth, New Jersey, Merck continues to expand its influence and maintain a significant presence in the life sciences sector.

Profile Details

Type

Depositary Receipt

Ceo

Mr. Robert M. Davis J.D.

Address

126 East Lincoln Avenue

City

Rahway

State

NJ

Zip

07065

Country

United States

Phone

908 740 4000

The information on this page is provided for general informational purposes only and is not investment advice.

Market data provided by Twelve Data. Charting by TradingView.

Last updated:

Depositary Receipt news

Track Global Markets in Real Time with UA Finance

Download the app now and access live financial data, expert analysis, and trusted economic news to follow stocks, forex, gold, and cryptocurrencies with ease.